Itchy inflammation of mosquito bites helps viruses replicate
Mosquito bite sites are not just itchy, irritating nuisances – they also make viral infections spread by the insects far worse, new research has found.
The study, led by the University of Leeds, found that inflammation where the insect has bitten not only helps a virus such as Zika or dengue establish an infection in the body more quickly, but that it also helps it to spread around the body, increasing the likelihood of severe illness.
"Mosquito bites are not just annoying – they are key for how these viruses spread around your body and cause disease," said Dr Clive McKimmie, a research fellow at the School of Medicine and senior author of the study.
"We now want to look at whether medications such as anti-inflammatory creams can stop the virus establishing an infection if used quickly enough after the bite inflammation appears."
In the new research, published in the journal Immunity, the investigators used mouse models to study the bites of the Aedes aegypti mosquito, the species that spreads infections such as Zika, dengue and Chikungunya.
When a mosquito bites, it injects saliva into the skin. The saliva triggers an immune response in which white blood cells called neutrophils and myeloid cells rush to the site.
But instead of helping, some of these cells get infected and inadvertently replicate the virus, the researchers found.
The team injected viruses into the skin of the mice with or without the presence of a mosquito bite at the injection site and compared the reaction.
In the absence of mosquito bites and their accompanying inflammation, the viruses failed to replicate well, whereas the presence of a bite resulted in a high virus level in the skin.
"This was a big surprise we didn't expect," said Dr McKimmie, whose team worked alongside colleagues at the University of Glasgow. "These viruses are not known for infecting immune cells.
"And sure enough, when we stopped these immune cells coming in, the bite did not enhance the infection anymore."
Despite the enormous disease burden of mosquito-borne viral infections – they are responsible for hundreds of millions of cases across the world – there are few specific therapies or vaccines.
"This research could be the first step in repurposing commonly available anti-inflammatory drugs to treat bite inflammation before any symptoms set in", said Dr McKimmie, whose study was funded by the Medical Research Council.
"We think creams might act as an effective way to stop these viruses before they can cause disease."
He added that if it is proven to be effective, this approach could work against a multitude of other viruses.
"Nobody expected Zika, and before that nobody expected Chikungunya," he said.
"There are estimated to be hundreds of other mosquito-borne viruses out there and it's hard to predict what's going to start the next outbreak."
The research paper, "Host inflammatory response to mosquito bites enhances severity of arbovirus infection", by Pingen et al, is available from the press office.
Dr Clive McKimmie is available for interview. Please contact Sophie Freeman in the University of Leeds press office on 0113 343 8059 or email [email protected]